29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
15 °P sammeln
  • Broschiertes Buch

The 1, 3, 4-oxadiazole compounds of different family emerged as a novel class of anticancer agents for biology and medicine I addition to their established antibacterial and antiviral properties. Among these novel heterocyclic compounds different derivatives of oxadaizole having core structures of imidazole, indole, and benzothiophene possessed anticancer properties Hence the present report on the anticancer properties of some novel core structures possessing 1, 3, 4-oxadiazole moiety largely influences the various concentrations of different cell lines used in the experiment. It also includes…mehr

Produktbeschreibung
The 1, 3, 4-oxadiazole compounds of different family emerged as a novel class of anticancer agents for biology and medicine I addition to their established antibacterial and antiviral properties. Among these novel heterocyclic compounds different derivatives of oxadaizole having core structures of imidazole, indole, and benzothiophene possessed anticancer properties Hence the present report on the anticancer properties of some novel core structures possessing 1, 3, 4-oxadiazole moiety largely influences the various concentrations of different cell lines used in the experiment. It also includes in vitro activity of different cancer cell lines which includes HeLa, Hep-G2, Caco2, MCF-7 etc. It takes this opportunity to express my heartfelt gratitude to all my collaborators, IISc (Indian Institute of Science), MCC (Mount Carmel College, Bangalore), IGNOU (Indira Gandhi National Open University), PPSIR (Poorna Prajna Scientific Industrial Research), Genelon Institute of Life Sciences.I great fully acknowledge the support of Prof. Sudha Medapa without which this book will not be prepared and published.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Vinayak Adimule, HOD and Assistant Professor of Chemistry in Jain College of Engineering and Technology, obtained his PhD from Indira Gandhi National Open University (IGNOU), New Delhi, India and has 10 years of Industrial R&D experience in the field of medicinal chemistry. He has published more than 30 research papers in international journal.